Table of Contents
Bone Marrow Research
Volume 2012, Article ID 259351, 9 pages
http://dx.doi.org/10.1155/2012/259351
Research Article

Differential Expression of Matrix Metalloproteinase-2 Expression in Disseminated Tumor Cells and Micrometastasis in Bone Marrow of Patients with Nonmetastatic and Metastatic Prostate Cancer: Theoretical Considerations and Clinical Implications—An Immunocytochemical Study

1Hematology, Division of Medicine, Hospital de Carabineros de Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, Chile
2Instituto de Bio-Oncología, Avenida Salvador 95, Oficina 95, Providencia, 7500710 Santiago, Chile
3Circulating Tumor Cell Unit, Faculty of Medicine, Universidad Mayor, Renato Sánchez 4369, Las Condes, 7550224 Santiago, Chile
4Faculty of Medicine, Universidad Diego Portales, Manuel Rodriguez Sur 415, 8370179 Santiago, Chile
5Faculty of Medicine, Universidad Pontificia Católica de Chile, Avenida Libertador Bernardo O'Higgins 340, 8331150 Santiago, Chile
6Radiotherapy, Fundación Arturo López Pérez, Rancagua 899, Providencia, 7500921 Santiago, Chile

Received 21 May 2012; Accepted 18 October 2012

Academic Editor: Joseph H. Antin

Copyright © 2012 Nigel P. Murray et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • Yixuan Gong, Uma Chippada-Venkata, and William Oh, “Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression,” Cancers, vol. 6, no. 3, pp. 1298–1327, 2014. View at Publisher · View at Google Scholar
  • R. Nawroth, D. Weckermann, and M. Retz, “Prostata- und Harnblasenkarzinom,” Der Urologe, 2014. View at Publisher · View at Google Scholar
  • E.David Crawford, Nelson N. Stone, Evan Y. Yu, Phillip J. Koo, Stephen J. Freedland, Susan F. Slovin, Leonard G. Gomella, E.Roy Berger, Thomas E. Keane, Paul Sieber, Neal D. Shore, and Daniel P. Petrylak, “Challenges and Recommendations for Early Identification of Metastatic Disease in Prostate Cancer,” Urology, 2014. View at Publisher · View at Google Scholar
  • Kursat Oguz Yaykasli, Muhammet Ali Kayikci, Nesibe Yamak, Hatice Soguktas, Selma Duzenli, Ali Osman Arslan, Ahmet Metin, Ertugrul Kaya, and Omer Faruk Hatipoglu, “Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer,” Turkish Journal of Medical Sciences, vol. 44, no. 5, pp. 839–843, 2014. View at Publisher · View at Google Scholar
  • Nikolai F. Gamaleia, and Irina O. Shton, “Gold mining for PDT: Great expectations from tiny nanoparticles,” Photodiagnosis and Photodynamic Therapy, 2015. View at Publisher · View at Google Scholar
  • Eileen M. McNerney, and Sergio A. Onate, “New Insights in the Role of Androgen-to-Estrogen Ratios, Specific Growth Factors and Bone Cell Microenvironment to Potentiate Prostate Cancer Bone Metastasis,” Nuclear Receptor Research, vol. 2, 2015. View at Publisher · View at Google Scholar
  • Jee Yoon Shin, Soon Ki Hong, Sangtaek Oh, Sung-Ho Goh, Jungsug Gwak, Kwanghyun Lee, Won Sun Kim, and Bong Gun Ju, “SFMBT2 (Scm-like with four mbt domains 2) negatively regulates cell migration and invasion in prostate cancer cells,” Oncotarget, vol. 7, no. 30, pp. 48250–48264, 2016. View at Publisher · View at Google Scholar
  • Mohit Kumar Jolly, Marcelo Boareto, Bisrat G. Debeb, Nicola Aceto, Mary C. Farach-Carson, Wendy A. Woodward, and Herbert Levine, “Inflammatory breast cancer: a model for investigating cluster-based dissemination,” npj Breast Cancer, vol. 3, no. 1, 2017. View at Publisher · View at Google Scholar
  • Nigel P. Murray, “Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management,” Biological Research, vol. 51, no. 1, 2018. View at Publisher · View at Google Scholar
  • Yohann Loriot, Stéphane Supiot, Jean-Baptiste Beauval, Friederike Schlürmann-Constans, Gilles Pasticier, Paul Sargos, Philippe Barthélémy, Géraldine Pignot, Denis Maillet, Sébastien Vincendeau, Emmanuel Gross, Guillaume Ploussard, Marc-Olivier Timsit, and Delphine Borchiellini, “Management of non-metastatic castrate-resistant prostate cancer: a systematic review,” Cancer Treatment Reviews, 2018. View at Publisher · View at Google Scholar
  • Frank C. Cackowski, and Russell S. Taichman, “Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation,” Bone, 2018. View at Publisher · View at Google Scholar
  • Frank C. Cackowski, and Russell S. Taichman, “Minimal Residual Disease in Prostate Cancer,” Biological Mechanisms of Minimal Residual Disease and Systemic Cancer, vol. 1100, pp. 47–53, 2018. View at Publisher · View at Google Scholar